Posted: 4/30/2013
|
Pharma IQ takes a closer look at the 30 pharmaceutical contract manufacturing innovators to watch in 2013.... Full Article » |
-
What is an ELN? by Michael Elliott Watch Now »
-
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem Watch Now »
-
Protecting your Pharma Intellectual Property during Out-Licensing Watch Now »
-
Drive Successful Commercial Product Launches through Effective Key Packaging Watch Now »
-
Follow Good Weighing Practice™ (GWP®), the Global Weighing Standard, and learn about Accurate Weighing in the Pharmaceutical Industry Watch Now »
- Intelligent Drug Development Applied to Drug Transporters 5/17/2013
- Top 10 Statistics From Pharma IQ's Clinical Trial Supply Survey 5/17/2013
- Angelina Jolie and the Maturity of Genomics 5/16/2013
- How High Level Information and Hypothesis-Driven Research can Accelerate Industrial Drug Design- Dr Simon Newstead 5/15/2013
- ...If it Quacks Like a Duck, it's Homeopathy 5/14/2013
- Infographic: Clinical Trial Supply USA 5/13/2013
Intelligent Drug Development Applied to Drug Transporters
Contributor: Gerald ClarkePosted: 5/17/2013
|
Drug design is growing up. Sophisticated, standardised, smart methods of developing new chemical entities (NCEs) are now the order of the day. No Topic shows this better than drug transporter proteins. Read about the latest research on this hot topic. Full Article » |
Luxembourg Ministry of the Economy and Foreign Trade's Daniel Liebermann on Cold Chain Logistics and Globalisation
Contributor: Daniel LiebermannPosted: 5/14/2013
Luxembourg Airport is the 5th largest air cargo hub in Europe. Daniel Liebermann, Deputy Director, Luxembourg Ministry of the Economy & Foreign Trade, speaks about the special characteristics of pharmaceutical logistics in Luxembourg, and how he has seen the role of the logistics provider change in recent years. Full Video » |
How High Level Information and Hypothesis-Driven Research can Accelerate Industrial Drug Design- Dr Simon Newstead
Contributor: Gerald ClarkePosted: 5/15/2013
|
Dr Simon Newstead explores why uptake transporters are important in drug development, the merits of a structure based analysis, the impact of the recent ITC recommendations and how they will impact research in the next 5 years. Full Podcast » |
GDP Guidelines Infographic: Focus on Nordic Pharma Supply
Posted: 5/14/2013The last few years have seen substantial change in the way that supply chains are run in the Nordic region. Three years ago, the de-regulation of the Swedish pharmacy market radically altered pharmaceutical supply chains and also threatened the role of traditional wholesalers within the supply chain. Find out what GDP Guidelines are impacting the region Full Whitepaper » |
-
16th Software Design for Medical Devices
May 20-22, 2013,
Hilton San Diego Resort & Spa, San Diego, CA -
Compound Management & Integrity - May 2013
May 21-23, 2013,
Thistle Marble Arch , London, United Kingdom -
4th Anti-Counterfeiting for Pharmaceuticals
May 22-24, 2013,
Renaissance Philadelphia Airport, Philadelphia, PA
|
|
different tactics that you would use for product marketing strategies suck as pre launch, launch, post launch? |
Posted by: leiasantos34 | Answer this question
|
|
different tactics that you would use for product marketing strategies |
Posted by: leiasantos34 | Answer this question
|
|
Is it possible with a MEG (Magnetoencephalography) to measure the neural activitu or the VLPO (neuron firings)? |
Posted by: Insomnia | Answer this question
|
|
what is the requirement of chewable tablet bioequivalance study for brazil and what are the general |
Posted by: ramesh89pharma | Answer this question
|
|
what is the requirement of chewable tablet bioequivalance study for brazil and what are the general |
Posted by: ramesh89pharma | Answer this question
Andrea Charles |
About Pharma IQ
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical and biotechnology professionals with knowledge, information and biotechnology articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical and biotech community.
|




















Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!